In SCLC, the canonical activation of the NOTCH pathway enhances HES1 expression, subsequently suppressing the expression of Achaete-scute homolog 1 (ASCL1) and inhibiting neuroendocrine DLL3-medited differentiation. Here, HES1 is linked to small cell lung carcinoma.